Share Tweet

Fosamax Lawsuit Won by Florida Woman

After a four year fight with Merck & Co. a Florida woman was awarded by a jury for $8 million with a claim that Fosamax damaged her jaw.The trail verdict represents a major milestone in litigation that numbers around 900 lawsuits pending against Merck by nearly 1,280 patient groups who claim Fosamax damaged their jawbone tissue.This is just some of the newest Fosamax Lawsuit News.

A recent study from the American Bone & Mineral Research has shown that 94% of osteoporosis patients who suffered a rare femur fracture had been taking bisphosponate drugs like Fosamax.In a lot of the cases the report shows that many of the fractures had occurred when the patient was doing low-impact tasks such as walking down a flight of stairs.Reports of these femur fractures from people using Fosamax started as early as 2007.During the same year a report published in The Journal of Bone and Joint Surgery profiled 13 women with low-trauma leg fractures, 9 who were long-term users of Fosamax

Several other class action lawsuits have already begun in Canada that have dealings with Fosamax and with the Florida women receiving money against Merck, it could lead to many other class action lawsuits in the United States as well.Most of the patients filing against Merck are claiming that Fosamax, a prescription medication used to treat and prevent osteoporosis by increasing bone density and strength, has actually deteriorated their bones, causing a condition known as osteonecrosis of the jaw (or death of jawbone tissue) and contributing to femur fracturesMerck rebuttals that these allegations are false and that Fosamax is a safe and effective medication.

In 2008, the U.S. Food and Drug Administration (FDA) contacted Merck & Co. Inc., the maker of Fosamax, about reports of femur fractures associated with the drug.It wasn’t until October 2010, however that the FDA announced it would require makers of bisphosphonates to add the risk of femur fracture to the Warnings and Precautions section of the drug labeling and provide patients with a medication guide warning of the risks.

The most common prescribed use of Fosamax is for treatment for menopausal osteoporosis. Fosamax has been the topic of much scrutiny as of late and is said to be includable in a pharmaceutical category called bisnosphonates.The drugs in this particular category have been connected to thigh fractures.Fosamax has been known to cause other serious side effects as well.
52 - 11 - 0 - US